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Abstract 
Typhoid is a major public health problem caused by Salmonella typhi. Salmonella typhimurium (S. typhimurium) causes an 
invasive disease in mice that has similarity with human typhoid. The antibiotics used got resistant to the bacteria and has side 
effects while vaccine developed has little scope against this disease. In this study antioxidant activity of fruits of Emblica 
officinalis was explored against the oxidative stress generated by S. typhimurium in mice. Animals pretreated with EO500 for a 
period of 30 days followed by challenged with 50000 (CFU) of S. typhimurium exhibit a decrease in Xanthine oxidase activity 
by 36% and increase in glutathione peroxidase and glutathione reductase activity by 37% and 38% respectively as compared 
to mice infected with same doses of S. typhimurium.  The study confirmed the lowering of oxidative stress in mice by this drug 
and can be used in typhoid. 
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Introduction 
Salmonellosis are wide spectrum diseases for 
men and animals. Salmonella typhi (S. typhi) is the 
causative organism for human typhoid is a world 
wide problem as described by this author also1. It is 
characterized by high fever, diarrhea, inflammation, 
colic pain. S. typhi has been reported to cause 
hepatic dysfunction and hepatic abscess2. In our 
review article on typhoid, we also reported a number 
of symptoms of this disease3. The present treatment 
of typhoid is antibiotics and vaccination. A major 
draw back to the effective chemotherapy of typhoid 
is the ever-increasing numbers of resistant strains of 
S. typhi4, 5, 6. The vaccines used against this disease 
are Ty21a and Vi.  However, the efficacy of Ty21a 
and Vi vaccines in children aged less than two years 
has not been explained, and neither of these 
vaccines are licensed for use in this age group as 
reported by WHO7. The resistant to antibiotic and 
limited scope of vaccine attracted the author to 
explore the efficacy of plant product against this 
disease. 
A number of diseases develop in the body due to 
unbalance in the body between pro-oxidant and anti-oxidant 
homeostatic phenomenon. The increased generation of free 
radicals or their poor scavenging develops the pro-oxidant 
condition8. Bacterial entrance into the body causes the 
production of nitric oxide and superoxide. Nitric oxide and 
superoxide react together to form peroxynitrite which  is  a 
strong biological oxidant. The role of peroxynitrite  molecule is 
to initiate lipid peroxidation, damages DNA, oxidizes thiol 
groups and modifies amino acetyl groups on protein. This 
oxidation and damage initiates a series of pathological 
conditions in the body leading to symptoms of diseases. The 
ability of Salmonella to replicate within the macrophages 
makes this enteric pathogen to cause disseminated 
disease. In pathological conditions there is an increase in the 
production of NO and superoxide anion which enhances the 
production of peroxynitrite. Consequently, pathological 
conditions characterized by oxidative stress can greatly 
elevate the production of peroxynitrite9. Further this author 
also reported the oxidative stress in mice caused by 
S.typhimurium10, 1. 
 
Herbal medicine has been improved in most of 
the developing countries not only as a way to 
rescue ancient tradition but also as an alternative 
solution to health problems. Medicinal herbs 
represent a rich source from which novel 
antibacterial chemotherapeutic agents could be 
obtained. We also reported a number of plants 
having high medicinal value in our review article on 
medicinal plants11.  
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Triphala the combination of Emblica officinalis 
(ES), Terminalia chebula and Terminalia bellarica in 
equal ratio is used in fever, cough, asthma, 
rheumatism, and inflammation of the lungs. 
Terminalia bellarica was reported to be used against 
Salmonella typhimurium (S.typhimurium) from the 
laboratory of our University12. It was reported by the 
author that aqueous extract of Terminalia chebula 
exhibit antisalmonella typhimurium activities invitro 
and also invivo13. The author further reported that 
the animals pretreated with aqueous extract of 
Terminalia chebula at a dose of 500mg/kg body wt 
orally exhibited protection against 100000 CFU of S. 
typhimurium injected intraperitoneally1, 13. As the 
extract of the fruits of the above said plants showed 
its activity against S. typhimurium, enabled the 
author to explore the activity of lyophilized juice of 
ES, a component of triphala against the oxidative 
stress generated by S. typhimurium. 
ES is also called as Amla or Indian gooseberry. 
It is used in jaundice, diarrhoea and has been 
reported to have antioxidant, antitumour, anti-
inflammatory activity14. In a review article on ES this 
author has described it as antimicrobial, 
hepatoprotective, antoxidant, immunomodulatory, 
antipyretic, analgesic, cytoprotective and also 
reported for having a number of other medicinal 
value15. The author studied the sign and symptoms 
of this disease and compared it with the biological 
activities of this plant which further enabled him to 
select the lyophilized juice of ES against S. 
typhimurium. Despite many therapeutic effects of 
Indian gooseberry, relatively little data is available 
on the antioxidant activity of Amla against oxidative 
stress induced by S. typhimurium. Therefore an 
invivo study was performed to determine the 
antioxidant effect of lyophilized fruit juice against S. 
typhimurium in mice.  
This author reported the protective effect of this 
drug (EO500) against the enzymes of oxidative 
stress induced in swiss albino mice against 
salmonella typhimurium16. The present study is the 
extension of the previous work. In this study the 
effect of lyophilized juice of ES were mainly studied 
on other enzymes of oxidative stress namely 
xanthine oxidase (XO), glutathione peroxidase 
(GPX) and glutathione reductase (GR) induced 
experimentally by S. typhimurium in mice. 
S. typhimurium causes an invasive disease in 
mice that has similarity with human typhoid17. 
Consequently, the murine model of salmonellosis 
has been used extensively to explain potentially 
clinical relevant mechanisms of antisalmonella host-
defense18, 19, 20, 21. The aim of this study is therefore 
to evaluate the efficacy of the lyophilized juice of ES 
against S. typhimurium in mice so to develop herbal 
drugs with no side effect against typhoid. 
Material and Methods 
Plant material 
Emblica officinalis (ES) belongs to the family 
Euphorbiaceae. Fruits were purchased from Okhla market 
of New Delhi, India. Further it was authenticated by 
University taxonomist. Before processing, it was 
confirmed that the materials were freed from 
contamination, and had no microbial growth. 
Preparation of plant extract  
Fruits of (ES) were washed thoroughly with double 
distilled water to remove dust particle and other impurities. 
Fruits were then deseeded and crushed to obtain juice. 
The juice collected were centrifuged at 3000 rpm for 10 
minutes and filtered in sterile condition and finally 
lyophilized to obtain dry powder (EO). Since EO is 
hygroscopic care was taken to handle this drug.  
Microorganisms 
The microorganism used in the experiment was S. 
typhimurium (wild). The standard strain of this pathogen 
was obtained from National Salmonella Phage Typing 
Centre, Lady Harding Medical College, New Delhi, India. 
This strain was further characterized and authenticated in 
the Department of Microbiology, Majeedia Hospital, New 
Delhi, India. Further it was confirmed by growing on Triple 
Sugar Iron (TSI) agar as it produces black colony against 
pinkish background. The confirmed colonies were then 
selected for the experimental purposes.  
Animals 
Swiss albino mice weighing 20-25 gms were used as 
an animal model for this study. These animals were 
supplied by Central Animal House, Hamdard University, 
New Delhi-62 and kept under standard laboratory 
condition for 12 hr light dark cycle at 25 10 oC.  Mice 
were provided with pellet diet (Lipton, India) and water ad 
labitum. Protocol was approved by Jamia Hamdard, 
Hamdard University, New Delhi-62, India where this work 
was done. All the studies were conducted according to 
ethical guidelines of the Jamia Hamdard Animal Ethics 
committee and ―Commiittee for the Purpose of Control 
and Supervision of Experiments on Animals‖ 
(CPCSEA). Much care was taken during the handling and 
maintenance of the mice in an ethical manner. 
Dose and Dosage 
The drug was prepared in saline. The dose of 
S. typhimurium was calculated and prepared 
according to Nasser22. Drug was administered 
orally and S. typhimurium intraperitoneally into 
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animals. The animals were divided into groups 
having six animals in each group. The study 
comprised of following treatment schedule. 
Group S: Normal saline. 
Group S+B: Normal Saline+50000CFU of S. 
typhimurium (wild). 
Group EO500: Lyophilised juice of Emblica officinalis 
(500mg/kg body wt).  
Group EO500+B: Lyophilised juice of Emblica 
officinalis (500mg/kg body wt)+ 50000CFU of S. 
typhimurium (wild). 
Biochemical estimations 
For this study eighteen swiss albino mice were taken. 
They were then carefully distributed into three groups. 
There were six animals in each group. First and second 
groups were pretreated with saline and third group with 
EO500 orally for a period of 30 days. After pretreatment 
for 30 days the mice in second and third groups were 
subjected to a challenge dose of 50000 CFU of S. 
typhimurium intraperitoneally. The animals of all groups 
(S: Animals pretreated with saline only for 30 days, S+B: 
Animals pretreated with saline for a period of 30 days 
followed by challenge with 50000 CFU of S. typhimurium. 
EO500+B: Animals pretreated orally with EO500 followed 
by challenge with same doses of bacteria) were sacrificed 
at 7th day of post infection (PI). For all biochemical 
estimation, post mitochondrial supernatant was used. 
Precaution was taken to complete all biochemical 
estimations within 24 hrs of animal sacrifice. 
Preparation of post-mitochondrial supernatant 
(PMS)  
Livers of the experimental animals were aseptically 
removed and then homogenized in chilled phosphate 
buffer (0.1 M, pH 7.4) containing KCl (1.17% w/v) using 
potter elvehjem homogenizer. The homogenate obtained 
was subjected for centrifugation at 800g for 5 min at 4 C 
to separate the nuclear debris. The aliquot obtained was 
again centrifuged at 10,500g for 20 min to obtain PMS. 
Enzymes were estimated by using PMS. 
Xanthine oxidase (XO) estimation 
The activity of XO was measured by the procedure 
adopted by Ali et al23. Reaction mixture consisting of 0.1 
mM xanthine and 0.5 M Tris-HCl buffer (pH 8.1) was 
incubated with appropriate amount of enzyme source for 
20 min at 37°C. The reaction was stopped by precipitating 
the enzyme using 10% perchloric acid. The mixture was 
then centrifuged at 4000 rpm for 10 min. Uric acid in the 
clear supernatant was determined at 290 nm. Results are 
expressed as mg of uric acid/mg protein. 
Estimation of glutathione peroxidase (GPX) 
GPX activity was assayed according to the method of 
Mohandas et al24.  The mixture consisted of 1.44 ml PO4 
buffer (0.05 M, pH 7.0), 0.1 ml EDTA (1 mM), 0.10 ml 
sodium azide (1 mM), 0.05 ml GR (1 IU/ml), 0.1 ml GSH 
(1 mM), 0.10 ml NADPH (0.2 mM), 0.01 ml H2O2 (0.25 
mM), and 0.1 ml PMS (10% w/v) in a total volume of 2.0 
ml. Disappearance of NADPH at 340 nm was recorded at 
room temperature. The enzyme activity was calculated as 
nmol NADPH oxidized/min/mg protein using a molar 
extinction coefficient of 6.22 x103 M-1cm-1. 
Estimation of glutathione reductase (GR) 
GR activity was assayed by the method of Mohandas 
et al24.  The assay system consisted of 1.60 ml of sodium 
phosphate buffer (0.1 M, pH 7.4), 0.1 ml of EDTA (0.5 
mM), 0.05 ml of oxidized glutathione (1 mM), 0.1 ml of 
NADPH (0.1 mM), and 0.15 ml of PMS (10% w/v) in a 
total volume of 2.0 ml. The enzyme activity was quantified 
by measuring the disappearance of NADPH at 340nm at 
30-s intervals for 3.0 min. The activity was calculated 
using a molar extinction coefficient of 6:22 x103 M-1cm-1 
and is expressed as nmol NADPH oxidized/ min/mg 
protein. 
Protein estimation 
Protein in all samples was determined by the method 
of Lowry et al25 using bovine serum albumin as a standard. 
Statistical analysis  
The level of significance between different groups 
was analyzed by Dunett’s t-test after the application of 
analysis of variance (ANOVA). 
Results  
Fresh fruits (250 gms) produced 250 ml juice. The 
juice on lyophilization yields 32.8 gm of drugs (EO). 
XO level was significantly assessed in the mice liver 
in concerned with S. typhimurium infection. Animals 
pretreated with saline for a period of 30 days followed by 
challenge with S. typhimurium (S+B) showed increased 
XO activity by 89% at 7th day of PI as compared to saline 
treated control (S). Mice pretreated with EO500 for same 
period of time and then subjected to same doses of S. 
typhimurium (EO500+B) showed a reduced in XO activity 
by 36% as compared to S+B group (Fig 1). 
GPX activity was significantly assessed in the mice 
liver in concerned with salmonellosis. Mice pretreated with 
saline for a period of 30 days followed by challenge with S. 
typhimurium (S+B) showed a decrease in GPX activity by 
13 % at 7th day of PI as compared to saline treated 
control (S). Animals pretreated with EO500 for 30 days 
followed by challenge with same doses of bacteria 
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(EO500+B) showed an increase in GPX activity by 37% 
as compared to SB group (Fig 2). 
Fig 1: Xanthine oxidase activity (mg uric acid formed/mg protein) induced 
by S. typhimurium in mice pretreated with EO for a period of 30 days. S = 
Saline, S+B = Saline+ 50000 CFU of S.typhimurium, EO500+B = 
Lyophilized juice of Emblica officinalis (500mg/kg body wt) + 50000 CFU  
of S. typhimurium. Values are significantly different. ***P< 0.001 
 
 
 
 
 
 
 
 
 
 
Fig 2: Glutathione peroxidase activity (n mole NADPH 
oxidized/min/mg protein) induced by S typhimyrium in mice 
pretreated with drug for a period of 30 days. S = Saline, S+B = 
Saline+ 50000 CFU of S.typhimurium, EO500+B = Lyophilized 
juice of Emblica officinalis (500mg/kg body wt) + 50000 CFU of 
S.typhimurium. Values are significantly different. ***P< 0.001 
 
 
 
 
 
 
 
 
The activity of GR was significantly determined in the 
mice liver in concerned with S.typhimurium infection. S. 
typhimurium infected saline group (S+B) showed a  decrease 
in GR activity by 22 % at 7th day of PI  as compared to saline 
treated control (S). The group pretreated with EO500 for a 
period of 30 days and challenged with same doses of 
bacteria showed an increase in GR activity by 38% as 
compared to S+B group (Fig3). 
Fig 3: Glutathione reductase activity (n mol NADPH reduced/min/mg 
protein) induced by S typhimurium in mice pretreated with drug for 30 
days. S = Saline, S+B = Saline+50000 CFU of S.typhimurium, EO500+B 
= Lyophilized juice of Emblica officinalis (500mg/kg body wt) + 50000 
CFU of S.typhimurium. Values are significantly different. ***P< 0.001 
 
 
 
 
 
 
Discussion 
Crude EO was deliberately used in this experiment in 
order to be faithful to the traditionally prescribed 
formulation. ES belongs to one of the Rasayana plant26. 
The main feature of Rasayana plants are to prevent 
ageing, strengthen life, reestablish youth, and brain power 
and prevent diseases27. They increase the resistance of 
the body against various drastic conditions. 
Chyawanprash is one of the ancient Ayurvedic 
preparation, which has been claimed to have health-
promoting effects and also used for various degenerative 
diseases. It contains ES as one of its major constituents28. 
Triphala, which is used in asthama, fever, cough, 
rheumatism, and inflammation of the lungs, contains ES, 
Terminalia chebula and Terminalia bellarica in equal 
proportion. ES was also reported to have antisalmonellae 
activity invitro by using well diffusion method29.  
S. typhimurium enterotoxin when exposed to isolated 
rat enterocytes resulted in an elevated XO activity30. This 
enzyme (XO) is capable of generating O2·– by converting 
hypoxanthine or xanthine to uric acid. XO is normally 
found in the liver. During severe liver damage, XO is 
released into the blood, so a blood assay for XO is a way 
to determine if liver damage has happened. 
In this experiment XO activity got increased in group 
SB, which in turn enhanced O2- production in liver. O2- 
radical has been of profound interest owing to its 
increased dominance invivo in different disease 
conditions. Oxidation of hypoxanthine to uric acid with 
simultaneous generation of O2- and H2O2 has been 
observed to play a crucial role during inflammatory 
condition and cancer.  Compounds which possess both 
the superoxide scavenging activity as well as XO 
inhibitory capacity are Quercitin,7-neohespiridosylluteolin, 
4,7-dimethyl quercitin, 3-rutinosylkaempferol. Quercitin is 
an important compound found in ES31. Thus it helps in 
reducing the production of uric acid by inhibiting XO. 
Decrease in uric acid production indicated liver to be in 
good rather than in damaged condition. The infection of 
mice with S. typhimurium caused damaged to liver as 
reported by us13. Infection of mice with S. typhimurium 
caused elevated level of uric acid thereby causing the 
increase of XO. In the present study it was shown that 
there is decrease in the level of uric acid in animals 
pretreated with EO500 followed by challenge with 50000 
CFU of S. typhimurium as compared to saline treated 
control challenged with same doses of same bacteria. 
Thus our study supports the effectiveness of this drug 
against S. typhimurium. Triphala has been reported to 
decrease the level of Xanthine oxidase, lipid peroxidation 
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and also restore the level of glutathione32 which further 
supports our study. 
The main function of glutathione peroxidase (GPX) is 
to protect the body from oxidative damage. It reduces lipid 
hydroperoxides to their corresponding alcohols and also 
reduces free hydrogen peroxide to water. They are the 
major enzymes that remove hydrogen peroxide generated 
by SOD in cytosol and mitochondria by oxidizing the 
tripeptide glutathione (GSH) into its oxidized form (GSSG).  
GPX can catabolise peroxynitrite invitro33 and many 
other small biological molecules including glutathione, 
cysteine, methionine and tyrosine, can react with 
peroxynitrite or its toxic products. Peroxynitrite is known to 
inactivate GPX by the oxidation of essential thiol or 
selenol34. Therefore, in bacteria infected group the 
profound decrease in GPX activity could be the result of 
inactivation of GPX by peroxynitrite. Increased in the GPX 
activity by the herbs suggested to catabolize peroxynitrite 
and thus lowers salmonellosis. ES have been further 
reported to normalize the level of GPX in stress 
condition35, 36 which also supports our study.  
GR reduces glutathione disulfide (GSSG) to the 
sulfhydryl form GSH, which is an important cellular 
antioxidant. The group treated with EO500 followed by 
challenge with 50000CFU  of S. typhimurium (EO500+B) 
showed elevation in levels of GR activity as compared to 
saline treated group (S+B) challenged with same doses of 
same bacteria. This again showed the protective effects 
of drugs against S. typhimurium. Further, ES have been 
also reported further to increase GR activity36  which 
finally supports our study. 
Further in support of our study the literature 
described ES as an antioxidant also37, 38, 39, 40, 41. It 
provided protection against radiation42. It is reported to be 
used against oxidative stress during ischemic-reperfusion 
injury43 and also ameliorates hyperthyroidism and hepatic 
lipid peroxidation44.  
As far as phytochemical is concerned, ES is a good 
source of polyphenol, flavones, tannins and other 
bioactive substances that are strong antioxidant and 
might contribute to the healthy effect14. Flavonoids are 
plants polyphenols which are available in the fruits45. ES 
has been reported to contain, ascorbic acid, carotenoids, 
ellagic acid46. The fruit also contains phyllembic acid, 
gallic acid14, emblicanin A and emblicanin B47, geraniin, 
quercetin, quercetin 3--D-glucopyranoside, kaempferol 
3--D-glucopyranoside, isocorilagin, kaempferol31 and 
vitamin C48.  
Some studies reported that tannic acid is 
bacteriostatic or bactericidal to some Gram (+)ve and 
Gram (-) ve pathogens49. There have been reports of 
antimicrobial properties in gallic acid50 and in some 
gallate esters. Polyphenolic compounds of ES were 
reported for its anti oxidant acitivities by scavenging free 
radical. Gallic acid, ellagic acid, ascorbic acid, emblicanin 
A, and emblicanin B have been reported as free radical 
scavenger39. Gallic acid and tannic acid were also 
reported to have antioxidant activity51.  Moreover gallic 
acid was also reported to be a major compound that 
showed highest NO scavenging activity52. 
Ellagic acid scavenges peroxynitrite derived radicals and 
consequently inhibits peroxynitrite induced oxidation and 
nitration reactions53.   
Geraniin, quercetin 3--D-glucopyranoside, 
kaempferol 3--D-glucopyranoside, isocorilagin, quercetin, 
and kaempferol were reported for their antioxidant 
activity31. 5-hydroxymethylfurfural, gallic acid, -
daucosterol and ellagic acid were reported to exhibit high 
antioxidant activity14. Vitamin C in ES accounts for 
approximately 45-70% of the antioxidant activity48. A 
number of reports regarding the antioxidant activity of ES 
were also made54, 55, 39, 56, 57,58. 
Preliminary phytochemical screening of the plant 
extract gave positive test for alkaloids, tannins, phenolic 
compounds, carbohydrates and amino acids, which might 
be in part responsible for antipyretic and analgesic 
activities59. Thus the protective effect of this drug is 
considered due to the combined effect of the active 
principle present in the fruit through its antioxidant activity. 
Conclusion 
The author mainly studied the effect of EO on the 
enzymes of oxidative stress namely xanthine oxidase 
(XO), glutathione peroxidase (GPX) and glutathione 
reductase (GR) induced experimentally by S. typhimurium 
in mice. S. typhimurium induces the oxidative stress in 
mice by increasing the level of XO and decreasing the 
level of GPX and GR. The drugs further reduced the 
activity of XO and increased the level of GPX and GR. 
Thus the drug provided protection to infected mice by 
acting as an antioxidant and lowering the oxidative stress 
generated by S. typhimurium. This reduction in the 
oxidative stress confirmed the effectiveness of the drug 
against S. typhimurium and so can also be used against 
typhoid. The route used for the administration of this drug 
was oral. It is the requirement of the present time to 
evaluate the potential of this drug using other route 
against the above bacteria. Since crude extract has been 
used in this experiment so effort is required to purify the 
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active principle and study this protection at molecular 
level. Further the drug can be put forward for clinical trial 
in man against typhoid. 
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